An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia
NCT00460512
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1814
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Paliperidone ER
Sponsor
Janssen-Cilag International NV